CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression
Frontiers of Medicine · 2025
DOI: 10.1007/s11684-024-1122-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers of Medicine, 2025. Verfasst von Zhuo Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou University Medical College, Guiyang, 550025, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Histone-Lysine N-Methyltransferase, Carcinoma, Squamous Cell, Chromatin Assembly Factor-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou University Medical College, Guiyang, 550025, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, Chi…
- Guizhou University Medical College, Guiyang, 550025, China. gbzhou@cicams.ac.cn.
Zitieren
APA
Zheng, Z., Lin, Y., Guo, H., Liu, Z., Jie, X., Wang, G., & Zhou, G. (2025). CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1122-2
Vancouver
Zheng Z, Lin Y, Guo H, Liu Z, Jie X, Wang G, et al. CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression. Frontiers of Medicine. 2025. doi:10.1007/s11684-024-1122-2
BibTeX
@article{Zheng2025,
author = {Zheng, Zhuo and Lin, Yongfang and Guo, Hua and Liu, Zheng and Jie, Xiaoliang and Wang, Guizhen and Zhou, Guangbiao},
title = {CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression},
journal = {Frontiers of Medicine},
year = {2025},
doi = {10.1007/s11684-024-1122-2}
}
EUVIMED